Contrary to some political claims, the U.S. Food and Drug Administration approved more drugs, and two to three months faster on average, than European regulators did in recent years, new research shows. “It’s an urban myth” that the FDA is slower than other countries to clear promising treatments for patients, says the agency’s longtime cancer…